Ythier; Arnaud
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ythier; Arnaud.The latest application filed is for "cladribine regimen for treating multiple sclerosis".
- Ythier; Arnaud - Collex-Bossy N/A CH
- Ythier; Arnaud - Collex-Bossy Geneva
| Patent | Date |
|---|---|
| Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules Grant 8,808,696 - Broly , et al. August 19, 2 | 2014-08-19 |
| Cladribine regimen for treating multiple sclerosis Grant 8,377,903 - De Luca , et al. February 19, 2 | 2013-02-19 |
| Methods for treating B-cell malignancies using a TACI-Ig fusion molecule Grant 7,842,292 - Broly , et al. November 30, 2 | 2010-11-30 |
| Cladribine Regimen for Treating Multiple Sclerosis App 20100203017 - De Luca; Giampiero ; et al. | 2010-08-12 |
| Cladribine regimen for treating multiple sclerosis Grant 7,713,947 - De Luca , et al. May 11, 2 | 2010-05-11 |
| Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules App 20070207156 - Broly; Herve ; et al. | 2007-09-06 |
| Methods for treating B-cell malignancies using a TACI-Ig fusion molecule App 20070071760 - Broly; Herve ; et al. | 2007-03-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 